AAC (NYSE:AAC) posted its quarterly earnings data on Friday. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.40), MarketWatch Earnings reports. AAC had a negative return on equity of 39.45% and a negative net margin of 26.42%. The company had revenue of $62.72 million for the quarter, compared to analysts’ expectations of $71.40 million. AAC updated its FY 2019 guidance to $-1.8–1.5 EPS.
NYSE:AAC traded down $0.09 during trading hours on Friday, hitting $0.60. The company’s stock had a trading volume of 494,830 shares, compared to its average volume of 246,986. The stock has a market capitalization of $14.92 million, a P/E ratio of -0.57 and a beta of 2.43. The stock has a fifty day moving average of $0.85 and a 200-day moving average of $1.52. The company has a current ratio of 0.17, a quick ratio of 0.17 and a debt-to-equity ratio of 3.37. AAC has a 52-week low of $0.50 and a 52-week high of $9.49.
In other AAC news, Director Lucius E. Burch III bought 51,003 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The shares were purchased at an average price of $0.81 per share, with a total value of $41,312.43. Following the completion of the acquisition, the director now directly owns 1,270,482 shares of the company’s stock, valued at approximately $1,029,090.42. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Stephen Ebbett bought 55,549 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was acquired at an average cost of $0.80 per share, for a total transaction of $44,439.20. Following the acquisition, the insider now directly owns 65,549 shares of the company’s stock, valued at $52,439.20. The disclosure for this purchase can be found here. Corporate insiders own 31.22% of the company’s stock.
AAC Holdings, Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention.
See Also: Call Option
Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with MarketBeat.com's FREE daily email newsletter.